Using a newly characterized and culturable murine NK cell line, we demonstrated that WEE1 kinase inhibition can be used to prevent G2/M cell cycle checkpoint activation and sensitize tumor cells to granzyme B-dependent NK lysis. The gene discussed is WEE1; the disease is neoplasm.